Luis Alvarez/DigitalVision via Getty Images
Background
In my last article, I analyzed the investment case of Seagen (SGEN) and noted the undervaluation of the company's core business. I think the company shares are more attractive now than at that
Seagen: SEA-CD40 Is The Next Growth Driver
Summary
- LV and SEA-CD40 represent the nearest growth drivers.
- A short-term positive could be a win in a patent dispute with Daiichi.
- According to my valuation, Seagen's target price is $193.
I am the head of research for the pre-IPO and venture division of the investment bank. Prior to that, I have been working as a global equity research analyst in an investment bank for the past 5 years. My specialization are Biotechnology, Internet and Media. I Received my CFA Charter in 2017. Also, I am FRM Charter. Besides, I am the author of the Russian-language Telegram-channel (the link in the section Website URL).
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in SGEN over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This is not investment advice. I am not an investment adviser. Before making any investment, please do your own research!
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.